Community Heritage Financial, Inc. announced a quarterly cash dividend of $0.08 per share, payable on November 6, 2026, to shareholders of record as of October 30, 2026. The company is the parent of Middletown Valley Bank, which provides personal and business banking services and mortgage lending. This dividend reflects the company's ongoing commitment to returning value to its shareholders. Investors can expect the dividend payment on the specified date as part of the company's regular shareholder distributions.
Community Heritage Financial, Inc. announced a third quarter 2026 dividend. For readers following Financials, here is Pluang's market snapshot as of Oct 20, 2026 02:12 WIB: out of 142 priced Financials-sector US stocks, 28 rose and 113 fell. Notable prices include COIN at USD 168.68 with a 1-day change of -2.59%, WFC at USD 81.75 with a 1-day change of -2.53%, and NWG at USD 17.07 with a 1-day change of -2.51%.
Dorchester Minerals, L.P. has agreed to acquire mineral and royalty interests covering about 4,300 net royalty acres in three counties within North Dakota's Williston Basin. The deal involves a non-taxable contribution and exchange agreement with an ...
The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...
W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...
GE Aerospace is set to report its Q3 earnings with analysts forecasting a 21.7% rise in earnings per share to $2.02 and nearly 12% revenue growth to about $12.7 billion. Despite consistently beating estimates, the stock has fallen after past reports ...
Silence Therapeutics' stock surged 125.6% to $19.58 following Merck KGaA's agreement to acquire the RNA-interference drug developer for about $1.3 billion in equity value. Merck will pay $20 per share, a 130% premium over the recent closing price. Ot...
